Rubano, Italy

Santina Quarta

This inventor holds 3 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignee: Universitá Degli Studi Di Padova. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Santina Quarta. Retrieved from https://idiyas.com/inventor/santina-quarta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.9

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Santina Quarta: Innovator in Fibrosing Disease Treatment

Introduction

Santina Quarta is a notable inventor based in Padua, Italy. She has made significant contributions to the field of medicine, particularly in the treatment of chronic fibrosing diseases. Her innovative work has led to the development of a unique compound that holds promise for patients suffering from these conditions.

Latest Patents

Santina Quarta holds a patent for 1-piperidinepropionic acid, which is designed for treating fibrosing diseases. This patent encompasses the compound itself, as well as its pharmaceutically acceptable salts and compositions that include it. The invention aims to provide a therapeutic option for chronic fibrosing diseases, showcasing her commitment to advancing medical science.

Career Highlights

Quarta is affiliated with the Università Degli Studi Di Padova, where she conducts her research and development work. Her academic background and ongoing research efforts have positioned her as a key figure in her field.

Collaborations

Throughout her career, Santina has collaborated with esteemed colleagues such as Mariagrazia Ruvoletto and Cristian Turato. These partnerships have enhanced her research and contributed to the advancement of her innovative projects.

Conclusion

Santina Quarta's work in developing treatments for fibrosing diseases exemplifies her dedication to improving patient outcomes through innovation. Her contributions to the field are significant and reflect her expertise as an inventor.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…